SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Shorts
XOMA 32.98-0.7%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: poodle who wrote (42)12/13/1997 11:48:00 PM
From: (no name provided)  Read Replies (1) of 61
 
Re: Stock buybacks. Check the history of VVUS. They announced a stock buyback when they got hammered earlier in the year. An announcement does not necessarily mean any stock ever gets bought back.

You probably know the short arguments re: ZONA already. Phentolamine has what is called in pharmacology a "narrow therapeutic window" meaning the effective dose (including that for impotence if you go by ZONA's data) is very close to the toxic dose.

Unlike MUSE, which you could probably take many (tens) of doses of without much significant side effects, two or three times the dose of phentolamine for impotence is likely to cause clinically significant hypotension.

Good luck and ZONA will go to zero eventually,

Kafka666
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext